Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000380668 | SCV000338429 | likely benign | not specified | 2015-12-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000954520 | SCV001101156 | likely benign | not provided | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000954520 | SCV005206098 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000954520 | SCV005410001 | uncertain significance | not provided | 2023-08-30 | criteria provided, single submitter | clinical testing | BP4 |
Prevention |
RCV003940009 | SCV004747371 | likely benign | SLC27A5-related disorder | 2021-03-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |